IMRT combined to IGRT: Increase of the irradiated volume. Consequences?;Radiothérapie conformationnelle avec modulation d'intensité (RCMI) guidée par l'image : Impact de l'augmentation du volume irradié à faible dose?

Cancer/Radiotherapie

Volumn 14, Issue 6-7, 2010, Pages 563-570

  Lisbona, A ^a   Averbeck, D ^b,c,d   Supiot, S ^a   Delpon, G ^a   Ali, D ^e   Vinas, F ^e   Diana, C ^e   Murariu, C ^e,f   Lagrange, J L ^e,f  

^a CLCC Nantes Atlantique   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c INSTITUT CURIE   (France)

^d CNRS   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Gene induction; IGRT low dose radiation effect; IMRT; Irradiated non tumoral volumes; Secondary tumor risk

Indexed keywords

BYSTANDER EFFECT; CARCINOGENESIS; CLINICAL PRACTICE; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SHORT SURVEY; CELL TRANSFORMATION; COMPUTER ASSISTED RADIOTHERAPY; DNA DAMAGE; EQUIPMENT DESIGN; GENE EXPRESSION; INSTRUMENTATION; METHODOLOGY; ORGAN SIZE; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; RADIATION INJURY; RADIATION RESPONSE; REVIEW; RISK; SECOND CANCER; TUMOR VOLUME;

BYSTANDER EFFECT; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; EQUIPMENT DESIGN; GENE EXPRESSION; HUMANS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; ORGAN SIZE; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RISK; TUMOR BURDEN;

EID: 77958166068     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.07.227     Document Type: Short Survey

References (95)

1. Aird E.G. Second cancer risk, concomitant exposures and IRMER (2000). Br J Radiol 2004, 77:983-985.
2. Alaei P., Ding G., Guan H. Inclusion of the dose from kilovoltage cone beam CT in the radiation therapy treatment plans. Med Phys 2010, 37:244-248.
3. Aoyama H., Westerly D., Mackie T., Olivera G., Bentzen S., Patel R.R., et al. Integral radiation dose to normal structures with conformal external beam radiation. Int J Radiat Oncol Biol Phys 2006, 64:962-967.
4. Averbeck D. Does scientific evidence support a change from the LNT model for low-dose radiation risk extrapolation?. Health Phys 2010, 97:493-504.
5. Averbeck D. Non-targeted effects as a paradigm breaking evidence. Mutat Res 2010, 687:7-12.
6. Azria D., Hennequin C. Prise en charge adjuvante des cancers invasifs du sein : les techniques de radiothérapie modifient-elles les taux de contrôle local et de survie ?. Cancer Radiother 2009, 13:434-445.
7. Azria D., Ozsahin M., Kramar A., Peters S., Atencio D.P., Crompton N.E.A., et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 2008, 14:6284-6288.
8. Bakkenist C.J., Kastan M.B. Initiating cellular stress responses. Cell 2004, 118:9-17.
9. Barquinero J.F., Barrios L., Caballin M.R., Miro R., Ribas M., Subias A., et al. Occupational exposure to radiation induces an adaptive response in human lymphocytes. Int J Radiat Biol 1995, 67:187-191.
10. Bauer G. Low-dose radiation and intercellular induction of apoptosis: potential implications for the control of oncogenesis. Int J Radiat Biol 2007, 83:887-902.
11. Belyakov O.V., Michell S.A., Parikh D., Randers-Pehrson G., Mazrino S.A., Amundson S.A., et al. Biological effects in unirradiated human tissue induced by radiation damage up to 1mm away. Proc Natl Acad Sci U S A 2005, 102:14203-14208.
12. Carbone M.C., Pinto M., Antonelli F., Amicarelli F., Balata M., Belli M., et al. The Cosmic Silence experiment: on the putative adaptive role of environmental ionizing radiation. Radiat Environ Biophys 2009, 48:189-196.
13. Charissoux M., Llacer Moscardo C., Fenoglietto P., Aillères N., Hay M.H., et al. Radiothérapie conformationnelle avec modulation d'intensité des cancers de prostate localisés : facteurs de récidive et de tolérance. Cancer Radiother 2009, 13:637-638.
14. Chera B.S., Rodriguez C., Morris C.G., Louis D., Yeung D., Li Z., et al. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75:1173-1180.
15. Collis S.J., Schwaninger J.M., Ntambi A.J., Keller T.W., Nelson W.G., Dillehay L.E., et al. Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J Biol Chem 2004, 279:4624-4632.
16. Corsetti D., Bellière A., Romestaing P. Optimization de la radiothérapie du sein : filtration, compensation électronique, modulation d'intensité. Cancer Radiother 2005, 9:411-413.
17. D'Souza W.D., Rosen I.I. Non-tumor integral dose variation in conventional radiotherapy treatment planning. Med Phys 2003, 30:2065-2071.
18. de Crevoisier R., Isambert A., Lisbona A., Bodez V., Marguet M., Lafay F., et al. Radiothérapie guidée par l'image. Cancer Radiother 2007, 11:296-304.
19. de Crevoisier R., Louvel G., Cazoulat G., Leseur J., Lafond C., Lahbabi K., et al. Radiothérapie guidée par l'image : pourquoi, comment et résultats. Bull Cancer 2009, 96:123-132.
20. Delpon G., Llagostera C., Le Blanc M., Rio E., Supiot S., Mahé M.-H., et al. Quelle radiothérapie guidée par l'image pour quels patients ? Expérience concomitante de l'utilisation de trois dispositifs d'imagerie de repositionnement dans le cas du cancer de la prostate. Cancer Radiother 2009, 13:399-407.
21. Downes P., Jarvis R., Radu E., Kawrakow I., Spezi E. Monte Carlo simulation and patient dosimetry for a kilovoltage cone-beam CT unit. Med Phys 2009, 36:4156-4167.
22. Elmore E., Lao X.-Y., Kapadia R., Redpath J.L. The effect of dose rate on radiation-induced neoplastic transformation in vitro by low doses of low-LET radiation. Radiat Res 2006, 166:832-838.
23. Feinendegen L.E., Pollycove M., Neumann R.D. Whole body responses to low-level radiation exposure. New concepts in mammalian radiobiology. Exp Hematol 2007, 35:37-46.
24. Feinendegen L.E., Pollycove M. Biologic responses to low doses of ionizing radiation: detriment versus hormesis. Part 1. Dose responses of cells and tissues. J Nucl Med 2001, 42:17N-27N.
25. Feinendegen L.E. Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol 2005, 78:3-7.
26. Followill D., Geis P., Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997, 38:667-672.
27. Fontenot J.D., Lee A.K., Newhauser W.D. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated X-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 2009, 74:616-622.
28. Franco N., Lamartine J., Frouin V., Le Minter P., Petat C., Leplat J.-J., et al. Low-dose exposure to gamma rays induces specific gene regulations in normal human keratinocytes. Radiat Res 2005, 163:623-635.
29. Frikha H., Chaari N., Nasr C., Bouguila H., Chebbhi A., Bhouri L., et al. Place de la radiothérapie dans le traitement du rétinoblastome : à propos de 40 cas. Cancer Radiother 2009, 13:30-36.
30. Goiten M. How best to dispose of extra-tumoral dose: a cautionary note for intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 2009, 75:1-3.
31. Hall E.J., Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003, 56:83-88.
32. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006, 65:1-7.
33. Hall E.J. The inaugural Frank Ellis lecture - Iatrogenic cancer: the impact of intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol) 2006, 18:277-282.
34. Harrison R.M. Second cancers following radiotherapy: a suggested common dosimetry framework for therapeutic and concomitant exposures. Br J Radiol 2004, 77:986-990.
35. Ikushima H. Radiation therapy: state of the art and the future. J Med Invest 2010, 57:1-11.
36. Islam M.K., Purdie T.G., Norrlinger B.D., Alasti H., Moseley D.J., Sharpe M.B., et al. Patient dose from kilovoltage cone beam computed tomography imaging in radiation therapy. Med Phys 2006, 33:1573-1582.
37. Johansen S., Cozzi L., Olsen D.R. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques. Acta Oncol 2009, 48:495-503.
38. Joubert A., Zimmerman K.M., Bencokova Z., Gastaldo J., Chavaudra N., Favaudon V., et al. DNA double-strand break repair defects in syndromes associated with acute radiation response: at least two different assays to predict intrinsic radiosensitivity?. Int J Radiat Biol 2008, 84:107-125.
39. Krasin M.J., Crawford B.T., Zhu Y., Evans E.S., Sontag M.R., Kun L.E., et al. Intensity-modulated radiation therapy for children with intraocular retinoblastoma : potential sparing of bony orbit. J Clin Oncol 2004, 16:215-222.
40. Kry S.F., Followill D., White R.A., Stovall M., Kuban D.A., Salehpour M. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys 2007, 68:1265-1271.
41. Kry S.F., Salehpour M., Followill D.S., Stovall M., Kuban D.A., White R.A., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005, 62:1195-1203.
42. Kry S.F., Salehpour M., Followill D.S., Stovall M., Kuban D.A., White R.A., et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005, 62:1204-1216.
43. Kry S.F., Salehpour M., Titt U., White R.A., Stovall M., Followill D. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy. Radiother Oncol 2009, 91:132-137.
44. Lagrange J.L., de Crevoisier La radiothérapie guidée par l'image IGRT. Bull Cancer 2010, 97:857-865.
45. Leseur J., Carrie C., Le Prisé é., Bernier V., Beneryton V., Mahé M.A., et al. Radiothérapie conformationnelle par modulation d'intensité des tumeurs pédiatriques. Cancer Radiother 2009, 13:536-542.
46. Lillicrap S.C., Morgan H.M., Shakeshaft J.T. X-ray leakage during radiotherapy. Br J Radiol 2000, 73:793-794.
47. Lisbona A., Delpon G. Les doses dues à l'imagerie numérique pour le contrôle de positionnement du patient en radiothérapie : comment les prendre en compte ?. Cancer Radiother 2008, 12:856-859.
48. Löbrich M., Jeggo P.A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 2007, 7:861-869.
49. Löbrich M., Rief N., Kühne M., Heckmann M., Fleckenstein J., Rübe C., et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci U S A 2005, 102:8984-8989.
50. Manusco M., Pasquali E., Leonardi S., Tanori M., Rebessi S., Di Majo V., et al. Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum. Proc Natl Acad Sci U S A 2008, 105:12445-12450.
51. Marcy P.Y., Zhu Y., Bensadoun R.J. Target volumes in radiotherapy - head and neck tumors intensity - modulated radiation therapy (IMRT) of nasopharyngeal carcinoma: practical aspects in the delineation of target volumes and organs at risk. Cancer Radiother 2005, 9:240-250.
52. Marinello G., Mège J.P., Besse M.C., Kerneur G., Lagrange J.L. Radiothérapie des cancers de la prostate : évaluation in vivo de la dose délivrée par tomographie conique de basse énergie (kV). Cancer Radiother 2009, 13:353-357.
53. Marples B. Is low-dose hyper-sensitivity a measure of G2-phase cell radiosensitivity?. Cancer Metastasis Rev 2004, 23:197-207.
54. Meeks S.L., Paulino A.C., Pennington E.C., Simon J.H., Skwarchuk M.W., Buatti J.M. In vivo determination of extra-target doses received from serial tomotherapy. Radiother Oncol 2002, 63:217-222.
55. Misteli T., Soutoglou E. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol 2009, 10:243-254.
56. Mokaouim K., Créhange G., Truc G., Peignaux K., Martin E., Zanetta S., et al. Traitement du carcinome du nasopharynx : de la radiothérapie conventionnelle à la radiothérapie conformationnelle avec modulation d'intensité. Cancer Radiother 2009, 13:677.
57. Morgan W.F., Sowa M.B. Non-targeted bystander effects induced by ionizing radiation. Mutat Res 2007, 616:159-164.
58. Munro A.J. Motes and beams: some observations on an IR(ME)R inspection in radiotherapy. Br J Radiol 2004, 77:273-275.
59. Murphy M.J., Balter J., Balter S., BenComo J.A., Das I.J., Jiang S.B., et al. The management of imaging dose during image-guided radiotherapy: report of the AAPM Task Group 75. Med Phys 2007, 34:4041-4063.
60. Mutic S., Low D.A. Whole-body dose from tomotherapy delivery. Int J Radiat Oncol Biol Phys 1998, 42:229-232.
61. Nguyen F. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields. Int J Radiat Oncol Biol Phys 2008, 70:908-915.
62. Oelfke U. IGRT and adaptive radiotherapy. Séminaire CPR/KSR. Radioprotection du patient dans le domaine médical. Berne; 2007.
63. Padovani L., André N., Carrie C., Muracciole X. Le médulloblastome de l'enfant et de l'adulte : quelle différence ?. Cancer Radiother 2009, 13:530-535.
64. Palm A., Johansson K.A. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Acta Oncol 2007, 46:462-473.
65. Palma D., Vollans E., James K., Nakano S., Moiseenko V., Shaffer R., et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:996-1001.
66. Peñagaricano J. Integral radiation dose to normal structures with conformal external beam radiation: in regards to Aoyama et al. (Int J Radiat Oncol Biol Phys 2006 64:962-7). Int J Radiat Oncol Biol Phys 2006, 65:1274-1275.
67. Peng LC, Yang CC, Sim S, Weiss M, Bielajew A. Dose comparison of megavoltage cone-beam and orthogonal-pair portal images. J Appl Clin Med Phys 2006 27;81:10-20.
68. Plowman P.N., Cooke K., Walsh N. Indications for tomotherapy/intensity modulated radiation therapy in paediatric radiotherapy: extra-cranial disease. Br J Radiol 2008, 81:872-880.
69. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III radomized trial. Int J Radiat Oncol Biol Phys 2002, 53:1097-1105.
70. Portess D.I., Bauer G., Hill M.A., O'Neill P. Low-dose irradiation of non transformed cells stimulates the selective removal of precancerous cells via intercellular induction of apoptosis. Cancer Res 2007, 67:1246-1253.
71. Purdy J.A. Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques. Health Phys 2008, 95:666-676.
72. Redpath J.L., Short S.C., Woodcock M., Johnston P.J. Low-dose reduction in transformation frequency compared to unirradiated controls: the role of hyper-radiosensitivity to cell death. Radiat Res 2003, 159:433-436.
73. Reese A., Das S., Curle C., Marks L. Integral dose conservation in radiotherapy. Med Phys 2009, 36:734-740.
74. Rothkamm K., Löbrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc Natl Acad Sci U S A 2003, 100:5057-5062.
75. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
76. Stovall M., Smith S.A., Langholz B.M., Boice J.D., Shore R.E., Andersson M., et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 2008, 72:1021-1030. Women's Environmental, Cancer, and Radiation Epidemiology Study Collaborative Group.
77. Taghian A.G., Kozak K.R., Doppke K.P., Katz A., Smith B.L., Gadd M., et al. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2006, 64:1092-1099.
78. The B.S., Mai W.Y., Grant 3rd W.H., Chiu J.K., Lu H.H., Carpenter L.S., et al. Intensity-modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control. Cancer Invest 2002, 20:437-451.
79. Thierens H., Vral A., Barbé M., Meijlaers M., Baeyens A., Ridder L.D. Chromosomal radiosensitivity study of temporary nuclear workers and the support of the adaptive response induced by occupational exposure. Int J Radiat Biol 2002, 78:1117-1126.
80. Tubiana M., Aurengo A., Averbeck D., Masse R. Recent reports on the effect of low doses of ionizing radiation and its dose-effect relationship. Radiat Environ Biophys 2006, 44:245-251.
81. Tubiana M., Aurengo A., Averbeck D., Masse R. The debate on the use of linear no threshold for assessing the effects of low doses. J Radiol Prot 2006, 26:317-324.
82. Tubiana M, Diallo I, de Vathaire F. A new method for assessing the dose-carcinogenic effect relationship in patients. Health Phys 2010 [sous presse].
83. Tubiana M., Feinendegen L.E., Yang C., Kaminski J.M. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology 2009, 251:13-22.
84. Tubiana M. La prévention du cancer et la relation dose-effet : l'effet cancérogène des rayonnements ionisants. Cancer Radiother 2009, 13:238-258.
85. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 2009, 91:4-15.
86. Valerie K., Yacoub A., Hagan M.P., Curiel D.T., Fisher P.B., Grant S., et al. Radiation-induced cell signalling: inside-out and outside-in. Mol Cancer Ther 2007, 6:789-801.
87. van der Laan H.P., Korevaar E.W., Dolsma W.V., Maduro J.H., Langendijk J.A. Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation. Radiother Oncol 2010, 94:235-240.
88. Waddington S.P., McKenzie A.L. Assessment of effective dose from concomitant exposures required in verification of the target volume in radiotherapy. Br J Radiol 2004, 77:557-561.
89. Wen N., Guan H., Hammoud R., Pradhan D., Nurushev T., Li S., et al. Dose delivered from Varian's CBCT to patients receiving IMRT for prostate cancer. Phys Med Biol 2007, 52:2267-2276.
90. Wolff S. The adaptive response in radiobiology: evolving insights and implications. Environ Health Perspect 1998, 106:277-283.
91. Xu X.G., Bednarz B., Paganetti H. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol 2008, 53:R193-241.
92. Yadav B.S., Sharma S.C., Patel F.D., Ghoshal S., Kapoor R.K. Second primary in the contralateral breast after treatment of breast cancer. Radiother Oncol 2008, 86:171-176.
93. Yang F., Stenoien D.L., Strittmatter E.F., Wang J., Ding L., Lipton M.S., et al. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation. J Proteome Res 2006, 5:1252-1260.
94. Yin E., Nelson D.O.E.S., Colemann M.A., Peterson L.E., Wyrobek A.J. Gene Expression changes in mouse brain after exposure to low-dose ionizing radiation. Int J Radiat Biol 2003, 79:759-775.
95. Zhang P., Happersett L., Hunt M., Jackson A., Zelefsky M., Mageras G. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys 2010, 76:1456-1462.